Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New androgen receptor modulators and their use in age-related conditions reported by BMS

March 19, 2003

Discovery of new compounds for diabetes and obesity accelerated at Yamanouchi

March 18, 2003

Novel PPAR agonists discovered by Merck researchers

March 18, 2003

Novel histamine H3 antagonists for use in obesity and diabetes

March 18, 2003

Hemosol to review safety data prior to continuing cardiac trial

March 18, 2003

BioMarin achieves positive phase II results for Aryplase

March 18, 2003

Phase II DX-88 study in angioedema completes patient treatment

March 17, 2003

Low-dose Prempro approved by FDA

March 17, 2003

Bayer claims novel glucose- and triglyceride-lowering agents for diabetes and other uses

March 17, 2003

Patient recruitment completed in phase IIb trial of ATL-962 for obesity

March 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...